Skip to content

Adverum Biotechnologies, Inc.: filings

Every Adverum Biotechnologies, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-11-12fiscal Q3 2025371100001628280-25-051593
10-Q2025-08-12fiscal Q2 2025351010001628280-25-039761
10-Q2025-05-14fiscal Q1 202535750001628280-25-025492
10-K2025-04-15fiscal FY 2024432920001628280-25-017767
10-Q2024-11-04fiscal Q3 2024371150001628280-24-045033
10-Q2024-08-12fiscal Q2 2024371110001628280-24-036769
10-Q2024-05-09fiscal Q1 202437790001628280-24-022236
10-K2024-03-18fiscal FY 202343870001628280-24-011648
10-Q2023-11-09fiscal Q3 2023381160001628280-23-038230
10-Q2023-08-10fiscal Q2 2023381120001628280-23-028851
10-Q2023-05-11fiscal Q1 202337790001628280-23-017564
10-K2023-03-30fiscal FY 202244890001628280-23-009899
10-Q2022-11-10fiscal Q3 2022381170001628280-22-029499
10-Q2022-08-11fiscal Q2 2022381130001628280-22-022469
10-Q2022-05-12fiscal Q1 202238810001628280-22-014088
10-K2022-03-29fiscal FY 202143870001628280-22-007698
10-Q2021-11-04fiscal Q3 2021361080001628280-21-021777
10-Q2021-08-05fiscal Q2 2021361050001628280-21-015877
10-Q2021-05-06fiscal Q1 202131670001628280-21-009293
10-K2021-03-01fiscal FY 202038970001628280-21-003623
10-Q2020-11-05fiscal Q3 202032920001628280-20-015761
10-Q2020-08-10fiscal Q2 202031840001628280-20-012332
10-Q2020-05-28fiscal Q1 202030640001628280-20-008534
10-K2020-03-12fiscal FY 201937730001564590-20-010503
10-Q2019-11-07fiscal Q3 201935950001564590-19-041787
10-Q2019-08-08fiscal Q2 201933830001564590-19-030765
10-Q2019-05-08fiscal Q1 201931600001564590-19-017203
10-K2019-03-06fiscal FY 201836960001564590-19-006536
10-Q2018-11-08fiscal Q3 201834830001564590-18-028654
10-Q2018-08-08fiscal Q2 201832780001564590-18-020510
10-Q2018-05-09fiscal Q1 201828560001564590-18-012437
10-K2018-03-06fiscal FY 2017341040001564590-18-004560
10-Q2017-11-08fiscal Q3 201728740001564590-17-022767
10-Q2017-08-08fiscal Q2 201728740001564590-17-016588
10-Q2017-05-09fiscal Q1 201728580001564590-17-009877
10-K2017-03-09fiscal FY 2016361090001564590-17-003759
10-Q2016-11-08fiscal Q3 201629750001564590-16-028352
10-Q2016-08-09fiscal Q2 201629750001564590-16-023738
10-Q2016-05-06fiscal Q1 201628580001564590-16-018295
10-K2016-03-04fiscal FY 2015341160001564590-16-014022
10-Q2015-11-09fiscal Q3 201529770001564590-15-010182
10-Q2015-08-13fiscal Q2 201529770001193125-15-290017
10-Q2015-05-13fiscal Q1 201529580001193125-15-185889
10-K2015-03-05fiscal FY 2014351150001193125-15-078923
10-Q2014-11-12fiscal Q3 201433870001193125-14-409201
10-Q2014-09-12fiscal Q2 201432870001193125-14-339410

Inspect the source

Entity
Adverum Biotechnologies, Inc. / CIK 0001501756
Captured
2026-09-21T17:19:30.277Z
SEC response SHA-256
3e3f88b341f4a0ffa9ee013477a8ae8ec2c292f96270a497f1b280e9a59501b4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001501756.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))